JAPAN ATOMIC INDUSTRIAL FORUM, INC.

for Japanese

ATOMS in JAPAN

26 November, 2019

Hitachi Receives Order from Mayo Clinic to Build First Carbon Ion Treatment System in North America

On November 20, Japan’s Hitachi, Ltd. announced that it had reached an agreement with the Mayo Clinic, in principle, to build North America’s first carbon ion treatment facility. The system will be constructed at the Mayo Clinic’s campus in Jacksonville, Florida, one of its three oncology centers, the others being in Minnesota and Arizona.

Upon the announcement, Gianrico Farrugia, M.D., president and CEO of the Mayo Clinic, said, “Carbon ion therapy has tremendous potential as a tool for treating patients with challenging cancers that do not respond well to currently available therapies.”

Keiji Kojima, executive vice president of Hitachi and in charge of its Smart Life Sector of Hitachi, expressed the firm’s desire to promote the system internationally, saying, “We are confident through our carbon experience, digital technology and the existing partnership with Mayo Clinic that we will continue to contribute to cancer treatment and increase our customer’s social value in the United States and across the globe.”

Domestically, Hitachi delivered the carbon ion treatment system to the Osaka Heavy Ion Therapy Center (HyBEAT) in 2018. Its first international order for the system came the same year, from the Taiwan Veterans General Hospital in Taipei.

Clinical tests of the carbon ion therapy system began in 1994 at the National Institute for Quantum and Radiological Science and Technology’s (QST’s) Heavy Ion Medical Accelerator in Chiba (HIMAC)—the pioneering device for charged-particle cancer therapy—as the world’s first specialized facility.

Subsequently, treatments have been carried out at the aforementioned HyBEAT in Osaka, as well as at Gunma University, the Kanagawa Cancer Center, the Hyogo Ion Beam Medical Center, and the Saga Heavy Ion Medical Accelerator in Tosu, Saga Prefecture, on the island of Kyushu.

According to a report presented by the QST in October to the Japan Atomic Energy Commission (JAEC), carbon ion therapy facilities are being increasingly provided primarily to other Asian countries by Hitachi and Toshiba Corporation, along with the Chinese Academy of Sciences’ Institute of Modern Physics. In South Korea, too, Toshiba’s system is expected to be put into service in 2022.

Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

SNS facebooktwitter

NPPs Map

Video

“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, July 2019)

8 July, 2019
“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, July 2019)09:17

Recent News

16 January, 2020
Japan’s Nuclear Power Plant Capacity Factor Stood at Just 21.4 Percent Last Year
26 December, 2019
IEEJ’s Supply-Demand Outlook for FY2020 Looks at Effect of Specific Safety Facility Installation Deadlines
25 December, 2019
ANRE Committee Clarifies Options for Treated Contaminated Water at Fukushima Daiichi NPPs, Viewing Both Offshore and Vapor Release Favorably
24 December, 2019
Fuel Removal from Fukushima Daiichi-1 NPP: Large Cover to be Installed First
18 December, 2019
JAEC Begins Hearing from University Personnel on Human Resource Development, Starting with Nagoya and Osaka Universities
13 December, 2019
NRA Approves Decommissioning Plans for Kansai EP’s Ohi-1 and-2
12 December, 2019
JAEA Holds International Forum on Peaceful Use of Nuclear Energy, Nuclear Non-Proliferation and Nuclear Security
29 November, 2019
NRA Issues Draft Review Report: Onagawa-2 Meets New Regulatory Standards
28 November, 2019
RIKEN Unveils Transportable Compact Neutron Source System
27 November, 2019
JAIF Releases Results of Fact-Finding Survey of Japanese Nuclear Industry for Fiscal 2018
▲TOP